NASDAQ:ADMS - Adamas Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$8.59 -0.13 (-1.49 %)
(As of 01/17/2019 08:00 AM ET)
Previous Close$8.72
Today's Range$8.55 - $8.89
52-Week Range$7.42 - $44.00
Volume418,100 shs
Average Volume609,490 shs
Market Capitalization$238.37 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Adamas Pharmaceuticals (NASDAQ:ADMS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for Adamas Pharmaceuticals in the last 12 months. Their average twelve-month price target is $30.7143, suggesting that the stock has a possible upside of 257.56%. The high price target for ADMS is $49.00 and the low price target for ADMS is $11.00. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.782.782.913.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $30.7143$31.7143$46.00$43.2222
Price Target Upside: 257.56% upside176.74% upside161.51% upside59.73% upside

Adamas Pharmaceuticals (NASDAQ:ADMS) Consensus Price Target History

Price Target History for Adamas Pharmaceuticals (NASDAQ:ADMS)

Adamas Pharmaceuticals (NASDAQ:ADMS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/14/2019HC WainwrightSet Price TargetBuy$40.00LowView Rating Details
1/11/2019MizuhoReiterated RatingHold$11.00MediumView Rating Details
11/12/2018Leerink SwannInitiated CoverageOutperform$20.00LowView Rating Details
11/1/2018CowenSet Price TargetBuy$30.00HighView Rating Details
10/5/2018Bank of AmericaDowngradeBuy ➝ Neutral$36.00 ➝ $25.00HighView Rating Details
4/22/2018Piper Jaffray CompaniesSet Price TargetBuy$49.00LowView Rating Details
2/25/2018Needham & Company LLCSet Price TargetBuy$40.00LowView Rating Details
2/23/2018Noble FinancialReiterated RatingBuyLowView Rating Details
2/21/2018William BlairReiterated RatingOutperformLowView Rating Details
11/29/2017Northland SecuritiesInitiated CoverageOutperform ➝ OutperformLowView Rating Details
10/30/2017Evercore ISIInitiated CoverageOutperformN/AView Rating Details
8/25/2017JMP SecuritiesReiterated RatingMkt Outperform ➝ Outperform$29.00 ➝ $33.00HighView Rating Details
(Data available from 1/17/2017 forward)
This page was last updated on 1/17/2019 by Staff

Featured Article: Analyst Ratings Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel